Pfizer Inc. v. Kelly

977 F.2d 754
CourtCourt of Appeals for the Third Circuit
DecidedOctober 8, 1992
DocketNos. 91-1887, 91-1917, 91-1943, 91-1981, 91-2105, 92-1014, 92-1053 and 92-1084
StatusPublished

This text of 977 F.2d 754 (Pfizer Inc. v. Kelly) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pfizer Inc. v. Kelly, 977 F.2d 754 (3d Cir. 1992).

Opinion

OPINION OF THE COURT

BECKER, Circuit Judge.

I.INTRODUCTION

Before us are eight petitions for mandamus brought by various defendants shortly before trial was scheduled to begin in this nationwide products liability class action. The trial, which has been stayed pending resolution of these petitions, will concern over 30,000 school districts’ claims that the defendants are liable for expenses incurred in eliminating the alleged danger caused by asbestos-containing products in their school buildings. The class action is founded on diversity jurisdiction and will be adjudicated according to the laws of fifty-four jurisdictions.

Petition No. 91-1887, filed by Pfizer, Inc. and supported by numerous other defendants, challenges the refusal of the district judge, the Honorable James McGirr Kelly, to disqualify himself from the case.1 Pfiz[770]*770er's petition first notes that Judge Kelly, pursuant to a previously established procedure, approved an ex parte request by the plaintiffs for $50,000 from a settlement fund to support a scientific conference on a key merits issue — the hazards of asbestos in place. The core allegation of the petition is that Judge Kelly attended, and had many of his expenses paid for, the resulting conference, which was an allegedly one-sided event at which most of the plaintiffs’ expected expert witnesses presented views similar to those they intended to express at trial.

According to the petition, Judge Kelly acknowledged the resulting appearance of impropriety, but, instead of disqualifying himself, he barred experts who appeared at the conference from providing any expert testimony at trial. Pfizer submits that this remedy is inadequate, and that the sole remedy under 28 U.S.C. § 455(a) for the appearance of partiality is disqualification. Pfizer also claims that Judge Kelly had to disqualify himself under 28 U.S.C. § 455(b) because by attending the conference he obtained personal knowledge of disputed facts.

In its petition, Pfizer asks only that we order Judge Kelly to disqualify himself. Two companion petitions, No. 91-1943 filed by ACandS, Inc. and No. 91-1981 filed by Asten Group, Inc., argue additionally that specific rulings adverse to them, which were issued after defendants first requested Judge Kelly to disqualify himself are tainted by the appearance of partiality and must be vacated. Another petition, No. 91-1917, filed by Kaiser Cement Corp., requests that we order the district court (1) to discontinue its process of approving, ex parte, the class plaintiffs’ use of escrowed settlement funds to defray litigation costs and (2) to unseal all the plaintiffs’ past applications for use of such funds and the district court’s rulings thereon.

Rejecting the contrary contention of the class plaintiffs, we conclude that mandamus is a proper means to force a district judge to disqualify himself or herself under 28 U.S.C. § 455. Furthermore, although we believe that Judge Kelly acted with integrity at all times, we also believe that the circumstances surrounding his attendance at the conference created an appearance of partiality that required disqualification under 28 U.S.C. § 455(a). A writ of mandamus disqualifying him shall therefore issue.

Such an order inevitably raises the question of what, if any, further remedy would be appropriate. We conclude, however, that none of Judge Kelly’s past orders need be vacated at this time. Furthermore, although we recommend that the newly assigned district judge delegate the task of reviewing the plaintiffs’ spending requests to a magistrate judge or a special master not otherwise involved in the case, we see no need to abolish the ex parte approval process altogether or to require the unsealing of past funding requests and the court orders approving them.

Two other mandamus petitions, No. 91-2105 filed by W.R. Grace & Co.-Conn. and No. 92-1053 filed by Georgia-Pacific Corp., request that we order the district court to adjudicate the merits of their respective motions for summary judgment. The district court refused to consider those motions on the ground that they were untimely, even though the court had not fixed any deadlines for filing such motions and had not set a firm trial date. We conclude that mandamus is a proper means to require a district court that has refused to consider the merits of an issue to do so. We further hold that a district court may only refuse to consider the merits of a summary judgment motion on grounds of untimeliness if it has previously set reasonable time limits on such motions or if the motion is made less than ten days from a formally fixed trial date so as to violate the ten day requirement of Federal Rule of Civil Procedure 56(c). While the conclusions we reach on these points are holdings because they are immediately binding on the parties be[771]*771fore the court and address rulings that otherwise would govern the case (i.e., they are not merely advisory), we realize that we cannot issue a writ of mandamus to a non-party, the newly assigned district judge. Accordingly, no writ of mandamus will issue with respect to the future consideration of the motions for summary judgment.

Finally, two petitions, No. 92-1014 filed jointly by Asten Group, Dana Corp., Pfizer, Pittsburgh Corning Corp., and W.R. Grace (“the joint petition”), and No. 92-1084 filed by Kaiser Cement, challenge the district court’s orders governing Phase I of the trial. Under the Phase I plan, the initial issue for trial is whether or not the defendants conspired and/or acted in concert to conceal the dangers of asbestos. The joint petition alleges that the district court lacks jurisdiction to try that issue first because, there having been no determination of liability for the underlying products liability tort, there can be no case or controversy with regard to the defendants’ joint and several liability for that underlying tort. The petition also alleges that the Phase I plan would violate the defendants’ Seventh Amendment rights because different juries would be called upon to decide inextricably interwoven factual issues.

Kaiser Cement’s petition alleges that the district court plans to try this diversity case according to a composite legal standard made up of the strictest standard from each of the jurisdictions (that is, the liability provisions least favorable to plaintiffs), instead of trying the claims from each jurisdiction according to the tort law of that jurisdiction. This scheme was originally suggested by the plaintiffs as a means of making the class action more manageable. Kaiser Cement, however, believes that such a scheme would violate the Supreme Court’s ruling in Phillips Petroleum Co. v. Shutts, 472 U.S. 797, 814-23, 105 S.Ct. 2965, 2976-80, 86 L.Ed.2d 628 (1985), that due process requires courts hearing multistate class actions to apply the substantive law of a state with a significant interest in having its law applied to a particular claim.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Roche v. Evaporated Milk Assn.
319 U.S. 21 (Supreme Court, 1943)
In Re Murchison.
349 U.S. 133 (Supreme Court, 1955)
Will v. United States
389 U.S. 90 (Supreme Court, 1967)
Will v. Calvert Fire Insurance
437 U.S. 655 (Supreme Court, 1978)
Phillips Petroleum Co. v. Shutts
472 U.S. 797 (Supreme Court, 1985)
Liljeberg v. Health Services Acquisition Corp.
486 U.S. 847 (Supreme Court, 1988)
In Re Harry W. Rodgers, III
537 F.2d 1196 (Fourth Circuit, 1976)
United States v. Hon. Judge Almeric L. Christian
660 F.2d 892 (Third Circuit, 1981)
Larry Bonner v. City of Prichard, Alabama
661 F.2d 1206 (Eleventh Circuit, 1981)
In Re United States of America
666 F.2d 690 (First Circuit, 1981)

Cite This Page — Counsel Stack

Bluebook (online)
977 F.2d 754, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pfizer-inc-v-kelly-ca3-1992.